Skip to main content

Systemic Lupus Erythematosus and Pregnancy

  • Chapter
  • First Online:
  • 1090 Accesses

Part of the book series: Rare Diseases of the Immune System ((RDIS))

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that affects predominantly women during their reproductive years. As expected, pregnancy is a common event in these women. A better understanding of the disease, the advances of the treatment, and creation of specialized multidisciplinary groups with experience in autoimmune diseases (involving physicians, obstetricians, pediatricians, and midwives) have led to dramatic improvement in disease management and pregnancy outcome over the last 20 years. However, maternal and fetal complications are still present. Risk factors for fetal and obstetric complications are disease activity at the conception and during pregnancy, lupus nephritis, arterial hypertension, positive antiphospholipid antibodies, and anti-Ro/SSA antibodies.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Donaldson LB, De Alvarez RR (1962) Further observations on lupus erythematosus associated with pregnancy. Am J Obstet Gynecol 83:1461–1473

    CAS  PubMed  Google Scholar 

  2. Ellis FA, Bereston ES (1952) Lupus erythematosus associated with pregnancy and menopause. AMA Arch Derm Syphilol 65:170–176

    Article  CAS  PubMed  Google Scholar 

  3. Khamashta MA (2006) Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 20:685–694

    Article  PubMed  Google Scholar 

  4. Cervera R, Font J, Carmona F, Balasch J (2002) Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev 1:354–359

    Article  PubMed  Google Scholar 

  5. Boumpas DT, Austin HA, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369

    Article  CAS  PubMed  Google Scholar 

  6. Ruiz-Irastorza G, Khamashta MA (2008) Lupus and pregnancy: ten questions and some answers. Lupus 17:416–420

    Article  CAS  PubMed  Google Scholar 

  7. Clowse MEB, Magder LS, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521

    Article  PubMed  Google Scholar 

  8. Lima F, Khamashta MA, Buchanan NMM et al (1996) A study of sixty pregnancies in patients with antiphospholipid syndrome. Clin Exp Rheumatol 14:131–136

    CAS  PubMed  Google Scholar 

  9. Ramsey-Goldman R, Kutzer JE, Kuller LH et al (1993) Pregnancy outcome and anti-anticardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 138:1057–1069

    CAS  PubMed  Google Scholar 

  10. Germain S, Nelson-Piercy C (2006) Lupus nephritis and renal disease in pregnancy. Lupus 15:148–155

    Article  CAS  PubMed  Google Scholar 

  11. Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101:1333–1344

    PubMed  Google Scholar 

  12. Brucato A, Frassi M, Franceschini F et al (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832–1835

    Article  CAS  PubMed  Google Scholar 

  13. Cuadrado MJ, Mendonca LLF, Khamashta MA et al (1999) Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 42:S265

    Google Scholar 

  14. Bonnin M, Mercier FJ, Sitbon O et al (2005) Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102:1133–1137

    Article  PubMed  Google Scholar 

  15. Mc Millan E, Martin WL, Waugh J et al (2002) Management of pregnancy in women with pulmonary hypertension secondary to SLE and antiphospholipid syndrome. Lupus 11:392–398

    Article  CAS  Google Scholar 

  16. Ostensen M, Khamashta MA, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209–227

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ostensen M, Lockshin M, Doria A et al (2008) Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology 47:28–31

    Article  Google Scholar 

  18. Clowse MEB, Magder L, Witter F et al (2006) Hydroxycloroquine in lupus pregnancy. Arthritis Rheum 54:3640–3647

    Article  PubMed  Google Scholar 

  19. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69:20–28

    Article  CAS  PubMed  Google Scholar 

  20. Buchanan NM, Toubi E, Khamashta MA et al (1996) Hydroxicloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55:486–488

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2003) Safety of hydroxycloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48:3207–3211

    Article  CAS  PubMed  Google Scholar 

  22. Mintz G, Nitz J, Gutierrez G et al (1986) Prospective study of pregnancy in systemic lupus erythematosus: results of a multi-disciplinary approach. J Rheumatol 13:732–739

    CAS  PubMed  Google Scholar 

  23. Lockshin MD, Reinitz E, Druzin ML et al (1984) Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 77:893–898

    Article  CAS  PubMed  Google Scholar 

  24. Urowitz MB, Gladman DD, Farewell VT et al (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397

    Article  CAS  PubMed  Google Scholar 

  25. Petri M, Howard D, Repke J (1991) Frequency of lupus flare in pregnancy: the Hopkins lupus pregnancy center experience. Arthritis Rheum 34:1538–1545

    Article  CAS  PubMed  Google Scholar 

  26. Ruiz-Irastorza G, Lima F, Alves J et al (1996) Increased rate of lupus flare during pregnancy and puerperium. Br J Rheumatol 35:133–138

    Article  CAS  PubMed  Google Scholar 

  27. Wong KL, Chan FY, Lee XP (1991) Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 151:269–273

    Article  CAS  PubMed  Google Scholar 

  28. Tandon A, Ibanez D, Gladman DD et al (2004) The effect of pregnancy on lupus nephritis. Arthritis Rheum 50:3941–3946

    Article  PubMed  Google Scholar 

  29. Levy RA, Vilela VS, Cataldo MJ et al (2001) Hydroxycloroquine in lupus pregnancy: double-blind and placebo -controlled study. Lupus 10:401–404

    Article  CAS  PubMed  Google Scholar 

  30. Cortes-Hernandez J, Ordi-Ros J, Paredes F et al (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 41:643–650

    Article  CAS  PubMed  Google Scholar 

  31. Khamashta MA, Ruiz-Irastorza G, Hughes GRV (1997) Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 23:15–30

    Article  CAS  PubMed  Google Scholar 

  32. Petri M (2007) The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin N Am 33:27–35

    Article  Google Scholar 

  33. Hayslett JP, Lynn RI (1980) Effect of pregnancy in patients with lupus nephropathy. Kidney Int 18:207–220

    Article  CAS  PubMed  Google Scholar 

  34. Jungers P, Dougados M, Pelissler C et al (1982) Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 142:771–776

    Article  CAS  PubMed  Google Scholar 

  35. Imbasciati E, Surian M, Bottino S et al (1984) Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron 36:46–51

    Article  CAS  PubMed  Google Scholar 

  36. Packham DK, Lam SS, Nicholls K et al (1992) Lupus nephritis and pregnancy. Q J Med 83:315–324

    CAS  PubMed  Google Scholar 

  37. Julkunem H (1998) Renal lupus in pregnancy. Scand J Rheumatol 27:80–83

    Article  Google Scholar 

  38. Huong DT, Wechsler B, Vauther-Brouzes D et al (1994) Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 87:721–729

    Article  Google Scholar 

  39. Oviasu E, Hicks J, Cameron JS (1991) The outcome of pregnancy in women with lupus nephritis. Lupus 1:19–25

    Article  CAS  PubMed  Google Scholar 

  40. Moroni G, Quaglini S, Banfi G et al (2002) Pregnancy in lupus nephritis. Am J Kidney Dis 40:713–720

    Article  PubMed  Google Scholar 

  41. Imbasciati E, Tincani A, Gregorini G et al (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24(2):344–347

    Google Scholar 

  42. Zulman J, Tala N, Hoffman GS et al (1980) Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol 7:37–49

    CAS  PubMed  Google Scholar 

  43. Bobrie G, Liote F, Houiller P et al (1987) Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 9:339–343

    Article  CAS  PubMed  Google Scholar 

  44. Carmona F, Font J, Moga I et al (2005) Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 53:182

    Article  PubMed  Google Scholar 

  45. Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14:89–94

    Article  CAS  PubMed  Google Scholar 

  46. Day CJ, Lipkin GW, Savage COS (2009) Lupus nephritis and pregnancy in the 21 st century. Nephrol Dial Transplant 24:344–347

    Article  PubMed  Google Scholar 

  47. Smyth A, Oliveira GH, Lahr BD et al (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5:2060–2068

    Article  PubMed  PubMed Central  Google Scholar 

  48. Milne F, Redman C, Walker J et al (2005) The preeclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. Br Med J 330:576–580

    Article  Google Scholar 

  49. Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112:359–372

    Article  PubMed  Google Scholar 

  50. Mackillop LH, Germain SJ, Nelson-Piercy C, Hughes GRV (2002) Effects of lupus and antiphospholipid syndrome on pregnancy. Yearb Obstet Gynecol 10:105–119

    Google Scholar 

  51. Askie LM, Duley L, Henderson-Smart DJ, PARIS Collaborative Group et al (2007) Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798

    Article  CAS  PubMed  Google Scholar 

  52. North RA, Ferrier C, Gamble C et al (1995) Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol 35:357–362

    Article  CAS  PubMed  Google Scholar 

  53. Sergio F, Maria Clara D, Gabriella F et al (2006) Prophylaxis of recurrent preeclampsia: low molecular weight heparin plus low dose aspirin versus low dose aspirin alone. Hypertens Pregnancy 25:115–127

    Article  PubMed  Google Scholar 

  54. Mecacci F, Bianchi B, Pieralli A et al (2009) Pregnancy outcome in systemic lupus erythematosus complicated by antiphospholipid antibodies. Rheumatology 48(3):246–249

    Article  CAS  PubMed  Google Scholar 

  55. Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in SLE and in non-SLE disorders. Ann Intern Med 112:682–698

    Article  CAS  PubMed  Google Scholar 

  56. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definitive antiphospholipid syndrome. J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  57. Lima F, Buchanan NM, Khamashta MA et al (1995) Obstetric outcome in systemic lupus erythematosus. Semin Arhtritis Rheum 25:184–192

    Article  CAS  Google Scholar 

  58. Opatrny L, David M, Kahn SR et al (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33:2214–2221

    CAS  PubMed  Google Scholar 

  59. Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039

    Article  CAS  PubMed  Google Scholar 

  60. Empson M, Lassere M, Craig J et al (2005) Prevention of recurrent miscarriages for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 18(2), CD002859

    Google Scholar 

  61. Petri M, Qazi U (2006) Management of the antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 32:591–607

    Article  Google Scholar 

  62. Ruiz Irastorza G, Khamashta MA (2007) Antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 33:287–297

    Article  Google Scholar 

  63. Carmona F, Font J, Azulay M et al (2001) Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate análisis. Am J Reprod Immunol 46:274–279

    Article  CAS  PubMed  Google Scholar 

  64. Ruiz Irastorza G, Khamashta MA, Hughes GRV (2002) Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1:298–304

    Article  CAS  PubMed  Google Scholar 

  65. Ruiz Irastorza G, Khamashta MA (2005) Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Am N Y Acad Sci 1051:606–612

    Article  CAS  Google Scholar 

  66. Ruiz Irastorza G, Khamashta MA, Nelson-Piercy C et al (2001) Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 10:597–600

    Article  CAS  PubMed  Google Scholar 

  67. Gordon P, Khamashta MA, Rosenthal E et al (2004) Anti-52 kDa Ro, anti-60 kDa Ro and anti La antibody profiles in neonatal lupus. J Rheumatol 31:2480–2487

    CAS  PubMed  Google Scholar 

  68. Buyon JP, Hiebert R, Copel J et al (1998) Autoimmune associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658–1666

    Article  CAS  PubMed  Google Scholar 

  69. Saleeb S, Copel J, Friedman D et al (1999) Comparison of treatment with fluorinated glucocorticoids to the national history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335–2345

    Article  CAS  PubMed  Google Scholar 

  70. Friedman D, Kim MY, Copel JA et al (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block (PRIDE) prospective study. Circulation 117:485–493

    Article  PubMed  Google Scholar 

  71. Pisoni CN, Brucato A, Ruffatti A et al (2010) Intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 62:1147–1152

    Article  CAS  PubMed  Google Scholar 

  72. Friedman DM, Llanos C, Izmirly PM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62:1138–1146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Izmirly PM, Kim MY, Llanos C, Le PU et al (2010) Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxycloroquine. Ann Rheum Dis 69:1827–1830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Ostensen M, Forger F (2013) How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol 13:1–6

    Article  Google Scholar 

  75. Fischer-Betz R, Specker C, Brinks R et al (2013) Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford) 52(6):1070–1076

    Article  CAS  Google Scholar 

  76. Auyeung-Kim DJ, Devalaraja MN, Migone TS et al (2009) Development and peri postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B lymphocyte stimulator. Reprod Toxicol 28:443–455

    Article  CAS  PubMed  Google Scholar 

  77. GlaxoSmithKline (2013) Use of intravenous (IV) benlysta in pregnant patients with systemic lupus erythematosus (SLE)

    Google Scholar 

  78. Peart E, Clowse MEB (2014) Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 26:118–123

    Article  CAS  PubMed  Google Scholar 

  79. Webster P, Wardle A, Bramham K et al (2014) Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus 0:1–5

    Google Scholar 

  80. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126(1):76–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Barsalou J, Jaeggi E, Tian SY et al (2014) A149: does prenatal exposure to antimalarial decrease the risk of neonatal lupus: a Bayesian perspective. Arthritis Rheumatol 66(Suppl 11):S193

    Article  Google Scholar 

  82. Ateka-Barrutia O, Khamashta MA (2013) The challenge of pregnancy for patients with SLE. Lupus 22:1295–1308

    Article  CAS  PubMed  Google Scholar 

  83. Cnossen JS, Morris RK, ter Riet G et al (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable metaanalysis. CMAJ 178:701–711

    Article  PubMed  PubMed Central  Google Scholar 

  84. Madazli R, Yuksel MA, Oncul M et al (2014) Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet 289(1):49–53

    Article  PubMed  Google Scholar 

  85. Morris RK, Malin G, Robson SC et al (2011) Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high risk population: systematic review and bivariate meta-analysis. Ultrasound Obstet Gynecol 37:135–142

    Article  CAS  PubMed  Google Scholar 

  86. Saavedra MA, Cruz-Reyes C, Vera Lastra O et al (2012) Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 31:813–819

    Article  PubMed  Google Scholar 

  87. Brito-Zeron P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. Nat Rev Rheumatol 2015;11(5):301–12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula Alba .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Alba, P., Khamashta, M. (2016). Systemic Lupus Erythematosus and Pregnancy. In: Roccatello, D., Emmi, L. (eds) Connective Tissue Disease. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-24535-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24535-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24533-1

  • Online ISBN: 978-3-319-24535-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics